These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19090931)

  • 1. Introduction. Key issues surrounding the treatment of acute coronary syndromes (ACS).
    Gibson CM; Watkins B; Merlo K
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S1-2. PubMed ID: 19090931
    [No Abstract]   [Full Text] [Related]  

  • 2. Now, I am proud to be a Radialist.
    Saito S
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):418-9. PubMed ID: 19681114
    [No Abstract]   [Full Text] [Related]  

  • 3. Updated ESC Guidelines for managing patients with suspected non-ST-elevation acute coronary syndromes.
    Eur Heart J; 2011 Dec; 32(23):2909-10. PubMed ID: 22135069
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel in the management of acute coronary syndromes: indications, results, obstacles.
    Amsterdam EA
    Crit Pathw Cardiol; 2009 Jun; 8(2):49-54. PubMed ID: 19491569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding associated with the management of acute coronary syndromes.
    De Silva K; Myat A; Cotton J; James S; Gershlick A; Stone GW
    Heart; 2017 Apr; 103(7):546-562. PubMed ID: 28087588
    [No Abstract]   [Full Text] [Related]  

  • 7. The year in non-ST-segment elevation acute coronary syndrome.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(13):1095-103. PubMed ID: 18848144
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventable deaths, never events, and comparative effectiveness: it is time for US cardiologist to switch to transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):416-7. PubMed ID: 19681112
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
    James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
    Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
    Husted S; Harrington RA; Cannon CP; Storey RF; Mitchell P; Emanuelsson H
    Int J Clin Pract; 2009 Apr; 63(4):667-70. PubMed ID: 19335707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.
    Alexander JH
    Cleve Clin J Med; 2009 Apr; 76 Suppl 1():S16-23. PubMed ID: 19332589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing bleeding risk in acute coronary syndromes.
    Erdem G; Flather M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):4-6. PubMed ID: 22056593
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging insights on antiplatelet therapy. Introduction.
    Angiolillo DJ
    Am J Cardiol; 2009 Feb; 103(3 Suppl):1A-3A. PubMed ID: 19166706
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
    Mariani M; Mariani G; De Servi S
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes.
    Riezebos RK; Ronner E; Ter Bals E; Slagboom T; Smits PC; ten Berg JM; Kiemeneij F; Amoroso G; Patterson MS; Suttorp MJ; Tijssen JG; Laarman GJ;
    Heart; 2009 May; 95(10):807-12. PubMed ID: 19098058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet agents used for early intervention in acute coronary syndrome: myocardial salvage versus bleeding complications.
    Aranki SF; Body SC
    J Thorac Cardiovasc Surg; 2009 Oct; 138(4):807-10. PubMed ID: 19769880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.